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1. Introduction 
Pituitary (hypophysis), the secreting gland located in the sella turcica, has fascinated the 
scientists since ages. In 1543 the Belgian scientist Andreas Vesalius described the anatomy of 
pituitary gland for the first time. He believed that pituitary produces mucus, which is 
secreted from the brain into the nasal cavity. This is why pituitary was called the mucous 
gland (glandula pituitaria; pituita = mucus). Pituitary gland, also called as „master gland” 
plays the special role in the body. There are plenty of pathological changes with different 
clinical and radiological appearances of lesions located in sellar and parasellar region. The 
knowledge of pituitary anatomy and function, as well as of the characteristic changes in size 
and shape of the pituitary throughout the life and special physiologic conditions, is 
mandatory for the correct diagnosis and therefore these factors have to be taken into account 
before assessing pituitary abnormalities. 
2. Imaging of pituitary gland 
Introduction of imaging modalities, especially magnetic resonance (MR), and of modern 
methods of neurosurgery and pharmacotherapy revolutionised diagnosis and therapy of 
pituitary tumours. Currently, MR is the method of choice for imaging of the pituitary gland 
and the parasellar area. Advanced MR techniques – MR diffusion, MR spectroscopy and MR 
perfusion – have been increasingly applied (Boxerman et al., 2010; Chernov et al., 2009). 
MR imaging protocol of pituitary and sellar region including postoperative studies should 
consist of unenhanced T1- and T2-weighted images in coronal and sagittal planes (slice 
thickness 3mm, field of view FOV=16x16). Paramagnetic contrast medium is administrated 
intravenously at the standard dose of 0.1 ml/kg BM and post-contrast T1-weighted images 
are taken in coronal and sagittal planes (Bladowska et al., 2004, 2011). 
MR examination enables visualization of many anatomic details of pituitary gland, such as: 
the anterior lobe (adenohypophysis), the posterior lobe (neurohypophysis), pituitary 
infundibulum, parasellar structures (cavernous sinuses, sphenoid sinus, suprasellar cisterns) 
and optic chiasm (Bladowska et al., 2004).  
The normal pituitary gland shows the homogenous signal intensity, which is isointense 
compared to the white matter signal on T1-weighted as well as on T2-weighted images 
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(Fig.1a,b). After contrast administration pituitary gland presents the homogenous strong 
enhancement (Fig.2a,b). 
The posterior lobe of the pituitary demonstrates the characteristic high signal intensity on 
T1- and T2-weighted images, seen just in front of the sellar dorsum and clearly 
differentiated from the anterior pituitary lobe. The high signal intensity of the posterior lobe 
is especially clearly visible on the sagittal planes (Fig. 3a,b) and it is called “posterior 
pituitary bright spot”. This high intensity signal observed in the posterior lobe is believed to 
be related to intracellular droplets of lipid or lipidlike material in pituicytes (astrocytic glial 
cells). However, the recent studies using the sequences with fat suppression have not 
confirmed the presence of fat tissue within the neurohypophysis (Arslan et al., 1999).  
Absence of this high intensity signal have been reported in patients with central diabetes 
insipidus (Fig.4a.b). It has to be stressed that some normal subjects lack this hyperintense  
 
A B
Fig. 1. MR imaging of normal pituitary gland in coronal planes before contrast 
administration: A. T1-weighted image. B. T2-weighted image. 
 
A B
Fig. 2. MR imaging of normal pituitary gland, T1-weighted images after contrast 
administration: A. Coronal plane. B. Sagittal plane. 
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A B
Fig. 3. MR imaging of normal pituitary gland in sagittal planes before contrast 
administration: A. T1-weighted image. B. T2-weighted image. The high signal intensity of 
the posterior lobe is clearly visible. 
 
A B
Fig. 4. MR imaging in sagittal planes before contrast administration, a 36-y.o. man with 
central diabetes insipidus. A. T1-weighted image. B. T2-weighted image. The high signal 
intensity of the posterior lobe is not visible. 
signal of the posterior lobe, therefore its absence cannot be taken as an absolute sign of 
pituitary disease or dysfunction (Evanson, 2002). 
The normal pituitary gland undergoes the characteristic changes in size and shape throughout 
the life, which have to be taken into account before assessing pituitary abnormalities.  
In neonates, the pituitary gland is typically convex and shows a higher signal intensity 
compared to the brain stem on T1-weighted images (Fig.5). This appearance persists for 
about 2 months, after which the pituitary will present with a flat superior surface and a 
signal intensity similar to the signal of the pons, what is typical for the older children. 
Throughout childhood, the pituitary reveals a slight but definite growth in all dimensions. 
The upper surface is flat or mildly concave and the height of the pituitary in the sagittal 
plane is about 2-6mm (Fig.6a,b), there are no differences between girls and boys.  
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Fig. 5. MR imaging in neonate, T1-weighted image in axial plane. The pituitary gland 
demonstrates the characteristic high signal intensity. 
A B
Fig. 6. MR imaging of normal pituitary gland in 5-y.o. boy, T1-weighted images.: A. Sagittal 
plane B. Coronal plane after contrast administration. 
At puberty the pituitary gland demonstrates the huge changes in size and shape, becoming 
larger than at any other time of the whole life. In girls the gland can reach the height of 
10mm, while in boys it may measure 7-8mm. Furthermore, in pubertal girls the gland can 
also project above the sella and present with a marked convexity of its superior surface 
(Elster, 1990, 1993). 
Physiologic hypertrophy of the pituitary can be observed during pregnancy, when the gland 
may increase in weight by 30%-100%. By the third trimester the pituitary usually measures 
even 10mm of height and shows the typical convex superior surface. It has to be stressed 
that during pregnancy and the 1st postpartum week, the pituitary gland demonstrates the 
www.intechopen.com
 Diagnostic Imaging of the Pituitary and Parasellar Region 
 
17 
high signal intensity on T1-weighted images (Fig.7), like in the neonate period (Bladowska 
et al., 2004; Elster, 1991, 1993).  
 
Fig. 7. MR imaging of the pituitary gland in 24-y.o. woman 5 days after delivery, T1-
weighted image in axial plane. The pituitary gland demonstrated the characteristic high 
signal intensity. 
From young adulthood until middle age, the pituitary glands of both sexes show usually 
stable appearance. Beyond age of 50 years, progressive involution of the gland is observed, 
what is probably related to the decrease in pituitary activity during menopause and 
andropause period. It has to be emphasized that in about 30% of this population the high 
signal intensity of the posterior pituitary lobe is not visible, as well as the empty sella 
syndrome is more commonly noted, but these changes are typical signs of normal aging 
process (Bladowska et al., 2004; Elster, 1993).  
3. Imaging of pituitary adenomas 
Pituitary adenomas constitute approximately 10 to 15% of all primary intracranial 
neoplasms and are the most common causes of pituitary function disorders and field of 
view deficits. Therefore, early diagnosis and therapy of patients with pituitary tumors are of 
high importance in clinical practice (Bladowska et al., 2010a).  
Pituitary adenomas are the most common pathology encountered in the sellar region. They 
are usually benign and slow growing tumors, but up to 50% reveal histological evidence of 
capsule invasion, furthermore less than 0.2% could be malignant, causing local spread into 
the central nervous system. Pituitary carcinoma is exceedingly rare. 
About 70% of pituitary adenomas are diagnosed in patients aged 30-50-y.o., while subjects 
in age below 20-y.o. constitute only 3 to 7% of all patients with pituitary tumors. Besides, 
pituitary adenomas are more common in women than in men (Daly et al., 2009). 
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Pituitary adenomas can be classified on the basis of their size: microadenomas are less than 
10mm in diameter and macroadenomas are greater than 10mm. It has to be stressed that the 
separate term “picoadenomas” should be used for describing the tumors smaller than 3mm, 
because these lesions are posing special diagnostic problems – it is often impossible to 
visualize the picoadenomas on MR imaging (Bonneville et al., 2000, 2005).  
Furthermore, clinically adenomas are classified depending upon the presence or absence of 
specific hormonal activity. They are divided into two groups: functioning pituitary 
adenomas and non-functioning adenomas. Functioning adenomas usually secrete a single 
hormone causing a well recognised endocrine syndrome like e.g. acromegaly (GH - growth 
hormone-secreting adenomas). 
In MR imaging, on T1-weighted images, about 80-90% of pituitary microadenomas present 
with lower signal intensity compared to the normal anterior pituitary lobe – they are 
hypointense. The other cases of microadenomas could be isointense and therefore they will 
be not visible on T1-weighted images before contrast administration. Pituitary 
microadenomas can also reveal high signal intensity on T1-weighted images, what may be 
caused by hemorrhagic transformation of the adenoma and this is a frequent sign in 
prolactinomas (PRL - prolactine-secreting adenomas). On T2-weighted images, about 1/3 to 
½ of microadenomas demonstrate high signal intensity (Fig.8), what is especially helpful in 
making the correct diagnosis of pituitary pathology. Increased signal intensity on T2- 
weighted images is noted in over 80% of microprolactinomas. The other types of pituitary 
microadenomas can present different signal intensity on T2- weighted images, iso or 
hypointense signal occurs in about 2/3 cases of GH-secreting microadenomas (Bonneville et 
al., 2005).  
 
A B
Fig. 8. MR imaging in coronal planes before contrast administration. A. T2-weighted image. 
B. T1-weighted image. On the right side of the pituitary gland there is a microadenoma, 
which shows the high signal intensity on T2- weighted image, making the correct diagnosis 
easy, while it is almost not visible on T1-weighted image. 
On the contrast-enhanced T1-weighted images microadenomas can show typically low 
signal intensity compared to the intense enhancement of the unaffected pituitary gland 
(Fig.9) (Bladowska et al., 2004).  
www.intechopen.com
 Diagnostic Imaging of the Pituitary and Parasellar Region 
 
19 
 
Fig. 9. T1-weighted image in coronal plane after contrast administration. The hypointense 
microadenoma is visible on the right side of the pituitary gland. 
It has to be emphasized, as mentioned above, the contrast-enhancement images may be 
normal in case of the extremely small tumor (picoadenoma). When the plain MR images are 
not convincing, other techniques can be also used. The delayed images taken about 30-40 
minutes after contrast administration may reveal late enhancement of the microadenoma 
itself (Bonneville et al., 2005). In our own material of pituitary adenomas we have noticed 
microadenomas, which show contrast-enhancement just about 10 minutes after injection of 
contrast (Fig.10a,b). 
A B
Fig. 10. T1-weighted sagittal images, before (A) and about 10 minutes after contrast 
administration. On the delayed image the enhancing microadenoma is clearly visible. 
The ACTH-secreting microadenomas associated with Cushing’s disease tend to be very 
small (typical feature of picoadenomas) and more often occult on MR imaging (Bonneville et 
al., 2005; Evanson, 2002). Dynamic imaging can be recommended in the diagnosis of ACTH- 
secreting microadenomas, when the clinical symptoms are highly suggesting of pituitary 
pathology, but the plain MR imaging is normal. Dynamic imaging can evidence a lack or a 
temporary delay of enhancement in the microadenoma compared to the unaffected pituitary 
gland. However, the delayed images taken at least about 10 minutes after contrast 
administration seem to be more useful in inconclusive cases. 
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The diagnosis of macroadenoma in MR imaging is usually simple because of the tumor size 
over 10mm, making the adenoma clearly visible, even in the computed tomography (CT). 
However, the other tumors may also be located in the sellar region and they can mimic 
pituitary adenomas. Therefore, the precise knowledge of the MR appearance of the 
macroadenomas is of high importance in the clinical practice. 
Macroadenomas are usually isointense on T1-weighted images, and after contrast 
administration they show different enhancement patterns (Fig.11, 12). On T2-weighted 
images they may be often inhomogenous, with disseminated high intensity areas of cystic 
degeneration or necrotic regions. About 18% of macroadenomas reveal the cystic 
components, while about 20% show features of haemorrhage, usually clinically 
asymptomatic and diagnosed incidentally in MR imaging. Large pituitary adenomas are 
prone to develop infarction or haemorrhage, because of their tenuous blood supply.  
 
A B
Fig. 11. T1-weighted coronal images before (A) and after contrast administration (B). The 
sellar-suprasellar macroadenoma shows strong contrast-enhancement. There is evidence of 
the optic chiasm and the third ventricle compression. 
A B
 
Fig. 12. T1-weighted coronal images before (A) and after contrast administration (B). The 
macroadenoma does not enhance after contrast injection. The compressed pituitary gland, 
showing the high signal intensity, is displaced to the left side of the sella. There is also the 
right cavernous sinus involvement. 
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Intratumoral hemorrhage is very often found in prolactinomas, especially after the 
treatment with bromocriptine. However, the hemorrhage may be revealed on MR images 
within adenomas in patients, who have not been treated (Bonneville et al., 2005). The 
hemorrhage shows the characteristic high intensity signal on T1-weighted images (Fig.13).  
A “fluid-fluid level” can be seen within the hemorrhage, and this feature is typical and more 
common in adenomas compared to other tumors, such as craniopharyngiomas. 
 
 
Fig. 13. T1-weighted coronal unenhanced image. The high intensity area of hemorrhage 
within prolactine-secreting macroadenoma is visible. 
Macroadenomas are intrasellar masses usually with extrasellar extension. They may grow 
upwards causing the optic chiasm compression and indent the floor of the third ventricle. 
These tumors can also extend downward into the sphenoid sinus, back into the dorsum 
sellae or laterally into the cavernous sinus. Involvement of the cavernous sinus can modify 
the prognosis, therefore the correct diagnosis is of high clinical importance, although it may 
remain difficult to differentiate compression and involvement. The complete encasement of 
the intracavernous part of the internal carotid artery (ICA) by the adenoma is the best sign 
of involvement of the cavernous sinus (Fig.14) (Bladowska et al., 2004).     
 
 
Fig. 14. T1-weighted coronal contrast-enhanced image. The complete encasement of the 
intracavernous part of the left internal carotid artery by the adenoma is visible. 
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4. Imaging of other pituitary tumors and parasellar lesions 
The most common pituitary tumors are adenomas, the other tumors constitute approximately 
5 to 10% of all sellar and parasellar lesions. The precise knowledge of the MR appearance of 
these lesions is of high importance in clinical practice, because they can mimic pituitary 
adenomas. In this subsection we describe the characteristic imaging features of these tumors. 
4.1 Craniopharyngiomas 
Craniopharyngiomas are the most common suprasellar lesions. They account for 
approximately 3% of all intracranial neoplasms and are slow-growing, benign tumors, 
which arise from squamous epithelial cell rests of Rathke’s pouch. These tumors are 
frequent in children and young adults, but they also can be found in older adults. 
Craniopharyngiomas may be divided into two histological types: adamantinomatous and 
squamous-papillary (Doerfler & Richter, 2008).  
In MR imaging the signal intensity of craniopharyngioma varies with cyst contents. High T1 
signal is the results of high protein content (Fig.15). The classic adamantinomatous type 
usually consists of hyperintense cysts and heterogeneous nodules. The less common 
papillary type is presented with isointense solid component. On T2-weighted images cysts 
are predominantly hyperintense, while the solid components show heterogeneous signal. 
After contrast administration the solid portions enhance heterogeneously, as well as cysts 
walls reveal strong enhancement (Bladowska et al. 2004; Doerfler & Richter, 2008).   
 
A B
Fig. 15. MR imaging in coronal planes before contrast administration. A. T1-weighted image. 
B. T2-weighted image. The sellar-suprasellar craniopharyngioma presents with high signal 
intensity on both T1- and T2-weighted images. 
4.2 Rathke’s Cleft Cyst 
Rathke’s cleft cysts account for approximately 1.5% of all sellar and parasellar lesions. They, 
like craniopharyngiomas, are also derived from the Rathke’s pouch, but are usually smaller 
and almost always located intrasellar, between the anterior and posterior pituitary lobe. 
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Furthermore, they present with different histological structure compared to 
craniopharyngiomas - Rathke’s cysts are lined by a single layer of epithelium, while 
craniopharyngiomas have thick walls composed of squamous or basal cells (Bladowska et 
al. 2004; Doerfler & Richter, 2008). 
Rathke’s cleft cysts are relatively common incidental findings, usually remaining 
asymptomatic. 
In MR imaging Rathke’s cleft cysts display variable signal intensity. Cysts containing serous 
fluid are typically hypointense on T1-weighted images and hyperintense on T2-weighted 
images (Fig.16), while mucoid cyst reveal high signal intensity on T1-weighted images and 
often characteristic very low signal on T2-weighted images (Fig.17). After contrast 
administration they usually do not enhance, although sometimes they can show very thin 
rim enhancement.  
 
A B
 
Fig. 16. MR imaging in coronal planes before contrast administration. A. T1-weighted image. 
B. T2-weighted image. Rathke’s cleft cyst containing serous fluid – it is hypointense on T1 
and hyperintense on T2-weighted image.  
A B
 
Fig. 17. MR imaging in sagittal planes before contrast administration. A. T1-weighted image. 
B. T2-weighted image. Rathke’s cleft cyst containing mucoid fluid – it is hyperintense on T1 
and hypointense on T2-weighted image. 
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Other cysts located in the sellar and parasellar region include: arachnoid, dermoid, 
epidermoid and colloid cysts (Bladowska et al., 2010c; Doerfler & Richter 2008). 
4.3 Meningiomas 
Meningiomas of the sellar region (cavernous sinus, planum sphenoidale, diaphragm sellae 
and clinoid process) account for about 11% of all sellar and parasellar tumors and for 20-
30% of all intracranial meningiomas (Doerfler & Richter 2008). They are slow-growing, 
usually benign tumors.  
 
 
 
Fig. 18. T1-weighted coronal contrast-enhanced image. The meningioma of the left 
cavernous sinus is visible. 
In MR imaging meningiomas are isointense compared to grey matter on T1-weighted 
images and isointense or slightly hyperintense on T2-weighted images. After contrast 
administration they reveal homogeneous enhancement (Fig.18). Often they present with 
characteristic so-called “dural tail sign”, what can help in differential diagnosis, but it has to 
be stressed that the “dural tail sign” is a nonspecific feature and may also be visible in other 
intracranial tumors. 
4.4 Other rare sellar and parasellar lesions 
Rare primary neoplasm of the pituitary and sellar region include: melanoma, intrasellar 
meningioma, germinoma, choristoma, glioma and metastases (Elster 1993; Ruscalleda 2005). 
Inflammatory and infectious lesions of pituitary and sellar region include: abscess (Fig.19) 
(Bladowska et al., 2010d), sarcoidosis, cysticercosis, Langerhans cell histiocytosis, 
blastomycosis, Wegener granulomatosis, Tolosa-Hunt syndrome, lymphocytic 
adenohypophysitis, giant cell granuloma and tuberculosis (Elster 1993; Doerfler & Richter 
2008).   
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A B
 
Fig. 19. MR imaging in coronal planes of the pituitary abscess. A. T2-weighted unenhanced 
image. B. T1-weighted contrast-enhanced image. There is characteristic strong rim 
enhancement visible. 
5. Postoperative MR imaging of pituitary and sellar region – own experience 
Post-surgical evaluation of the pituitary gland in MR is difficult because of a change in 
anatomical conditions. Interpretation of MR images taken after surgical therapy of pituitary 
tumors depends also on numerous other factors, including: size and expansion of a tumor 
before operation, type of surgical access, quality and volume of filling material and time of 
its resorption. Proper evaluation of post-surgical MR images is crucial for determination of 
completeness of the resection. Therefore neuro-radiologists face a responsible and difficult 
task of evaluation of structures present in the surgical area, and especially of differentiation 
of residual tumor from the implanted material and from post-surgical changes (fibrous and 
cicatrical), or even from a part of normal gland left at site (Bladowska et al., 2010a,b). 
In general, the residual tumors could be differentiated from postoperative changes by 
means of location, characteristic signal intensity and enhancing pattern, which should be 
similar to those in the preoperative MR imaging of the tumor. The infundibulum tilt could 
be additional factor suggesting the presence of residual adenoma. The endocrine studies are 
very helpful in postoperative diagnosis of hormone-secreting residual pituitary adenomas 
and are regarded as a method of choice in postoperative management of these tumors. It is 
especially difficult to evaluate the effectiveness of the surgical treatment of the 
nonfunctioning pituitary tumors, these tumors require a postsurgical MR follow-up 
examinations.  
The basic therapeutic method of pituitary tumors (apart from microprolactinoma) is 
surgery. Among several operation methods of the sellar region, the most frequently applied 
is the one with transnasal transsphenoidal approach. This method has widely forced  
out craniotomy and is now concerned the method of choice in the treatment of the majority 
of pituitary adenomas, both the hormonally active and inactive ones (Bladowska et al., 
2010b). 
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A characteristic feature of transsphenoidal surgery is the necessity of applying different 
filling materials to obtain haemostasis, to fill the resection site within the sella, and to inhibit 
the outflow of the CSF (cerebrospinal fluid).  
Filling materials are foreign or autogenic bodies that do not become vascularised. To sustain 
haemostasis, the following materials are used: oxidized cellulose (Oxycel or Surgicel), 
spongostan (Gelfoam), tissue glue (Tissucol or Beriplast), bone wax (to restrain bleeding 
from bone). Liquorrhoea requires a reconstructive operation of sella, with the use of 
autogenic fascia, lyophilisated dura mater or tissue glue. Next, the sella is sealed with a 
muscle or flakes of oxidized cellulose. To close the bottom of the sella, it is necessary to use a 
fragment of the collected cartilaginous septum from the nose, the vomer, or a silicon plate. 
To protect the postresection site and to reinforce the bottom of the sella, an autogenic fat 
graft is implanted in the sphenoid sinus. The graft is collected from the fatty tissue of the 
lateral part of the thigh or from the patient’s abdomen (Bladowska et al., 2010b). 
Application of the filling materials constitutes a considerable challenge in interpretation of 
the MR imaging results in patients who underwent surgery of the pituitary tumors. This can 
also lead to misdiagnosis. The knowledge of MR characteristics of the implanted materials is 
very important in postoperative diagnosis of pituitary tumors and may help to discriminate 
between tumorous and non-tumorous involvement of the sellar region (Bladowska et al., 
2010b). 
In the MRI examination, on T1-weighted images, Surgicel (Oxycel) is represented by a 
heterogeneous structure with a regular, oval shape, low signal intensity, surrounded by a 
hyperintense rim. Examinations performed in the first days after the procedure, frequently 
reveal the presence of small air bubbles closed in the strips of Surgicel, in the hypointense 
central part of the filling material (Bladowska et al., 2010b; Bonneville et al., 2003). 
Spongostan (gelfoam) is represented in the MRI examination by an intrasellar mass of signal 
intensity similar to that of the grey matter. In rare cases, spongostan may produce a 
heterogeneous high signal caused most probably by the presence of methemoglobin 
(Bladowska et al., 2010b; Bonneville et al., 2003). 
The similarity between signal intensity of the filling material, of the anterior pituitary lobe, 
and of a potential residual tumour often makes it difficult to interpret the image in an 
unequivocal way and to carry out a correct differential diagnosis. However, according to T. 
Kilic et al., spongostan and Surgicel (Oxycel) may be recognised only on an early performed 
MRI, i.e. within 24–48 hours after the procedure, because afterwards, the materials begin to 
undergo a progressive degeneration and their radiological identification becomes harder 
(Kilic et al., 2001). E. Steiner et al reported that these materials are normally recognisable on 
MRI for up to 3–6 months after the procedure (Steiner et al., 1992). Our studies showed that 
haemostatic materials may be identified only in the early postoperative period – in own 
material is was 1 month (Fig.20) (Bladowska et al., 2010b). 
After contrast administration, the central part of the haemostatic material remained 
hypointense, with peripheral rim of enhancement. This peripheral enhancement is caused 
by granulation tissue forming around the implanted material. Filling materials  
undergo changes which surely inhibit their identification. It should be underscored  
that a hypointense mass with peripheral enhancement after contrast administration is not 
characteristic for the filling material only. It may also correspond to the presence of a fluid  
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A  B 
Fig. 20. T1-weighted contrast-enhanced coronal images. A. Before operation – on the left side 
of the pituitary the microadenoma is visible (arrow). B. Follow-up MRI performed 1 month 
after surgery – there is haemostatic material implanted into the operation site (arrow). 
cistern, regions of necrosis within the tumor or cicatrical fibrous tissue with granulation 
around it (Bladowska et al., 2010b; Bonneville et al., 2003). 
In our own material, as much as 85.61% of the patients had their first postoperative MRI 
examination performed after 3 months following the procedure, and only 14.39% of the 
studied individuals (20 patients) – during the first 3 months. There were no examinations 
carried out within 24–48 hours from the procedure. When we consider the date of MRI 
examinations and the fast degeneration of the filling material, it is then easy to explain the 
fact why the haemostatic material was identified in only two patients of the studied group. 
The analysis of the conducted examinations revealed that the implanted autogenic fat and 
muscle with fascia, located in the lumen of the sphenoid sinus, can be observed on MRI for 
much longer (Bladowska et al., 2010b). 
Fatty tissue is not too difficult to identify, as it provides a characteristic signal of high 
intensity on T1-weighted images (Fig.21). There were reported cases of residual fatty 
material present in the sphenoidal sinus examined at 1–2 years after the procedure or even 
3–4 years afterwards. However, according to our assessments, the implanted fat may remain 
in place for much longer. The volume of the implanted fat influences the duration of its 
presence on MRI. Normally, the adipose tissue implanted in larger amounts (in case of 
macroadenoma resection) retains for much longer than the small amount of that material 
(implanted after microadenoma resection), absorbed within 9–12 months. 
As compared to other filling materials, identification of the fatty tissue in the MRI 
examination is easy thanks to the characteristic high signal intensity produced by the 
material, its longer persistence, but also the absence of adjacent contrast-enhanced areas 
formed by the granulation tissue. 
In the studied material, the implanted fatty tissue was identified in as many as 86 patients after 
pituitary tumour surgery. In the remaining 12 patients, who according to surgical reports were 
implanted fatty filling material, it was impossible to find that material on MRI. No fatty tissue 
found in these patients may result from a small amount of the implanted material, from its fast 
absorption, as well as from a longer postoperative time to MRI examination. 
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A B
Fig. 21. T1-weighted unenhanced sagittal images. A. MRI performed 10 months after 
transsphenoidal operation reveals the implanted fatty material inside the sphenoid sinus – it 
presents with high signal intensity. B. Follow-up MRI performed 23 months after surgery – 
there is no implanted material visible. 
The earliest total absorption of the fatty material was observed 11 months after the 
procedure. In most of the cases, residues of the adipose tissue were present for a long time, 
for even up to 112 months (nearly 10 years) after the procedure, while in one patient, there 
was a large amount of the fatty material still present in the lumen of the sphenoidal sinus 
after 348 months (29 years) (Bladowska et al., 2010b). 
In 2 patients, it was possible to visualise the implanted titanium mesh (Fig.22). On MRI, the 
titanium mesh was represented by a linear area producing no signal and located in the 
bottom of the sella (Bladowska et al., 2010b). 
 
A 
 
B
 
Fig. 22. MR imaging of implanted titanium mesh. A. T1-weighted coronal image. B. T2-
weighted coronal image. A linear area producing no signal and located in the bottom of the 
sella is visible.  
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In 3 individuals, an implanted muscle with fascia was identified. It was represented by a 
round, isointense structure, filling nearly the whole sphenoidal sinus on T1-weighted MRI 
images. After intravenous contrast administration, the structure was becoming slightly 
enhanced in its peripheral part, with a central round area of lower signal intensity (Fig.23a). 
Such an image of the implanted muscle was found in 2 patients after 4 months following the 
procedure, and in 1 patient after 5 months from surgery. The follow-up MRIs (beginning 
approx. from the 12th
 
postoperative month) were revealing a gradual change in the image of 
that material. After contrast administration, the previously distinct border between the 
enhanced peripheral part and the central hypointense part of the implanted muscle became 
indistinct. In further MRI examinations, performed approx. 25 months after surgery or later, 
the structure present in the lumen of the sphenoidal sinus remained hypointense after 
contrast administration. Without the analysis of previous images and the knowledge of 
patient’s history, the correct diagnosis of that mass on T1-weighted images was impossible 
(especially its differentiation from e.g. fluid cistern). The implanted muscle with fascia 
produced a very characteristic and almost stable image in T2-weighted sequence (Fig.23b), 
for at least 31 months following the procedure. In the T2-weighted sequence, the material is 
represented by a hyperintense mass with a linear structure, of a very low signal intensity, 
corresponding to fascia (Fig.23b). It should also be pointed out that fascia was not identified 
on T1-weighted images (Fig.23a) (Bladowska et al., 2010b, 2011). 
 
A B
Fig. 23. MR imaging of muscle with fascia implanted into the sphenoid sinus. A. T1-
weighted enhanced coronal image. B. T2- weighted unenhanced coronal image – the linear 
structure, of a very low signal intensity, corresponding to fascia is very well visible. 
The final diagnosis and evaluation of the surgical completeness on the basis of the 
performed MRI is often equivocal, in spite of the presence of the above mentioned criteria. 
It is especially hard to evaluate the effectiveness of the surgical treatment of the hormonally 
inactive tumors on the basis of the MRI examination results and their interpretation only. 
These tumors require a postsurgical endocrinological and MRI follow-up. 
Follow-up of abnormal structures present in the postsurgical area may allow for their 
verification. If in the following examinations there is a complete absorption of the focal 
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lesion, this excludes the presence of a residual tumor and indicates to the filling material or 
postoperative changes.  
If the size and volume of the pathological structure increases, this points to the presence of a 
residual tumor. On the other hand, it should be remembered that pituitary tumors grow 
slowly, so in a long-term follow-up, the tumor may seem stable, which does not facilitate the 
final diagnosis in unclear cases of hormonally inactive tumors. 
As mentioned above, the transsphenoidal approach is currently the method of choice in 
treatment of most of pituitary tumors. There are characteristic changes inside the sphenoid 
sinus after the surgery (Connor & Deasy, 2002). MRI findings of sphenoid sinus filling 
(opacification) are present in approximately 37% of examinations performed more than 12 
months after transsphenoidal surgery. The contrast enhancement at the margins of the 
sphenoid sinus, called as Rodriguez’s changes (Fig.24), is always apparent in cases of 
hypervascularized and swollen mucosa (Rodriguez et al., 1996) and could persist even 10 
years after surgery. 
 
A B
 
Fig. 24. MR imaging of Rodriguez’s changes, T1-weighted sagittal images: unenhanced (A), 
contrast-enhanced (B). There are hypointense masses inside the sphenoid sinus, which show 
the characteristic rim contrast enhancement.  
The special attention should be also paid to usefulness of T2-weighted images in assessment 
of postoperative sella and sellar region. T2-weighted images may help to discriminate 
between tumorous and non-tumorous involvement of the postoperative sella and the 
sphenoid sinus especially in cases, in which the signal intensity and enhancement pattern of 
pituitary gland and tumor are the same on T1-weighted images. T2-weighted images are 
also very useful in the postoperative evaluation of the implanted muscle with fascia, 
especially during long term follow-up. The best protocol for the postoperative imaging after 
pituitary tumor resections should include both T1- and T2-weighted imaging, because T1- 
and T2-weighted images supplement each other in the postoperative examination of the 
sella and sellar region. However, in some cases T2 could replace post-contrast T1, especially 
in patients with high risk of Nephrogenic Systemic Fibrosis (NSF) (Bladowska et al., 2011). 
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6. Conclusion 
Pituitary adenomas are common neoplasm, they account for 10-15% of all diagnosed 
intracranial tumors. The proper diagnosis and management of patients with pituitary 
lesions are of high importance in the clinical practice. Currently, MR is the method of choice 
for imaging of the pituitary gland and the parasellar area. MR imaging protocol of pituitary 
and sellar region including postoperative studies should consist of unenhanced T1- and T2-
weighted images in coronal and sagittal planes, followed by T1-weighted images after 
contrast administration. Because of so many pathological changes with different clinical and 
radiological appearances of the lesions located in sellar and parasellar region, the precise 
knowledge of pituitary lesions is mandatory for the correct diagnosis and management of 
patients with pituitary diseases.  
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